Introduction
============

Tuberculosis remains a public health threat with significant annual impacts on morbidity and mortality. Brazil is ranked 16th among the 22 high-burden countries that collectively account for 80% of tuberculosis (TB) cases globally, with an incidence of 33.5 cases/100,000 inhabitants/yr in 2014. The city of Porto Alegre has the highest incidence of TB in the country (99.3 cases/100,000 inhabitants/yr in 2014)[@B1].

At present, much of the attention of TB programs is focused on outcomes of microbiological cure and mortality, and health related quality of life (HRQL) is undervalued. HRQL may be fundamental in influencing treatment outcome. Studies showed that as compared with the general population, TB patients reported reductions in their physical health, psychological health, and social functioning[@B2][@B3]. There are several aspects of TB that may lead to deficits in HRQL, like social stigma, prolonged therapy, potentially toxic drugs, lack of knowledge regarding the disease and its treatment, anxiety, and depression[@B4][@B5][@B6][@B7].

TB patients have a significantly higher risk of developing depression compared with those in the general population[@B8]. Depression in individuals with TB is associated with delays in seeking health care and poor treatment compliance, that can lead to drug resistance, morbidity and mortality[@B9]. Rates of mental illness of up to 70% have been identified in TB patients[@B10]. In a study that evaluated hospitalized TB patients, depression was present in about 80%[@B11]. Anxiety disorder is also high among patients with TB[@B12]

The evaluation of HRQL and the identification of psychiatric comorbidities, such as depression and anxiety, in patients with TB are important for characterizing the physical and mental health of these patients. It is possible that these factors have an influence on treatment adherence, and their knowledge can enable a better understanding of the attitudes of these patients regarding their disease. Therefore, the aim of this study is to evaluate the HRQL, the prevalence of symptoms of depression and anxiety in hospitalized patients with TB, and to compare the characteristics of patients with and without depression, and with or without anxiety.

Materials and Methods
=====================

We conducted a cross-sectional study in a general, tertiary care, university-affiliated hospital with 750 beds, located in the city of Porto Alegre, Rio Grande do Sul State, in southern Brazil. The study was approved by the Ethics Committee at Hospital de Clínicas de Porto Alegre in January 22, 2013 (number 13-0022).

Adult patients (≥18 years old) with pulmonary TB that were hospitalized during the study period (January 2013--June 2015) were identified and invited to participate. We included only the patients who began treatment for TB after hospitalization. Patients who were already receiving treatment at admission, who are unable to comply with study procedures and those who refused signing the consent form were excluded from this study. Pulmonary TB was diagnosed according to the Brazilian Guidelines for Tuberculosis[@B13].

The following data were collected from patient records using a standardized data extraction tool: demographic data (sex, age, race, and years of schooling), behavioral data (smoking status, alcohol abuse, and injection drug use), and medical history (clinical form of TB, symptoms at admission, methods of diagnostic, presence of comorbidities, prior TB treatment, drug regimen, interval from hospital admission until diagnosis, length of hospital stay, intensive care unit \[ICU\] admission, length of mechanical ventilation, and hospitalization outcome \[death or discharge\]). A current smoker was defined as reporting smoking at least 100 cigarettes in their lifetime, and at the time of the survey were smoking at least one day a week. A former smoker was defined as reporting smoking at least 100 cigarettes in their lifetime but who, at the time of the survey, did not smoke at all. Never smoked reported having smoked \<100 cigarettes in their lifetime. Alcohol abuse was defined as daily consumption of at least 30 g (equivalent to a pint and a half of 4% beer) for men and 24 g (equivalent to a 175 mL glass of wine) for women. An independent physician analyzed the chest X-rays and classified them as typical or compatible with active TB, according to previously described guidelines[@B14].

HRQL was measured using the Medical Outcomes Study Short Form-36 (SF-36) version 2, which is a reliable, validated questionnaire[@B15][@B16]. This questionnaire contains eight domains assessing diverse aspects of health including physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health, and two summary measures, physical and mental components. For all the SF-36 domains, higher scores indicate better health. Brazilian normative data for the SF-36 version 2 were used for comparative purposes[@B17]. Scores of Brazilian men and women ranged according to age and gender were included as a [Supplementary Tables 1](#S1){ref-type="supplementary-material"} and [2](#S2){ref-type="supplementary-material"}.

Human immunodeficiency virus (HIV) positive patients also completed the World Health Organization Quality of Life instrument for HIV clients (WHOQOL-HIV). Several specific instruments for individuals with HIV are found in the international literature, but only the WHOQOL-HIV was validated for use in Brazil[@B18][@B19]. This questionnaire will be administered by the possibility of change in HRQL be related to HIV (and not tuberculosis, or even due to the two diseases). This instrument contains 31 items and for each item there is a fivepoint Likert scale where 1 indicates low or negative perceptions and 5 high or positive perceptions. These items contain six domains: physical health (4 items), psychological well being (5 items), social relationship (4 items), environmental health (8 items), level of independence (4 items), and spiritual health (4 items). There were two general questions about general QOL and perceived general health. The physical domain contained information regarding presence of pain, energy, and sleep. The psychological domain consisted of negative and positive feelings, self esteem, and thinking. The social domain covered social support, personal relationships and sexual activity. Mobility, work capacity, and activities were included in the level of dependence. Financial issues; home and physical environment; availability of transport; physical safety and security, and participation in leisure activities were included under the environmental domain. The spirituality domain did contain questions about death and dying; forgiveness and blame and concern about the future.

The Hospital Anxiety and Depression Scale (HADS)[@B20], previously validated in Brazil[@B21], was used to record symptoms of anxiety and depression. This questionnaire was developed to identify caseness (possible and probable) of anxiety disorders and depression among patients in nonpsychiatric hospital clinics, not with the diagnostic purpose, but as screening. It avoids recording details of the biological symptoms of depression that might arise as a result of the physical complaints. It is divided into an anxiety subscale (HADS-A) and a depression subscale (HADS-D) both containing seven questions. The overall score for each subscale goes from 0 to 21. Scores of 11 or above on the anxiety or depression subscale are taken as indicative of probable for either disorder.

Also, self-esteem was evaluated by Rosenberg\'s Self-Esteem Scale, validated in Brazil[@B22]. This is a one-dimensional measure, and consists of 10 statements related to a set of feeling of self-esteem and of self-acceptance that assesses global self-esteem. The items are answered in a Likert scale of four points: strongly agree, agree, disagree, and strongly disagree. The overall score goes from 10 to 40. Scores ≤15 indicate low self-esteem.

Data analysis was performed using SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). Data were presented as number of cases, mean±standard deviation, or median with interquartile range. Categorical comparisons were performed by chi-square test using Yates\'s correction if indicated or by Fisher exact test. Continuous variables were compared using the t test or Wilcoxon test. SF-36 results were compared with Brazilian normative data using a paired t test. A two-sided p-value \<0.05 was considered significant for all analyses.

Sample size calculation was based on a previous study[@B23]. Considering an expected proportion of 0.70 (prevalence of symptoms of depression and anxiety, 70%), an amplitude of the confidence interval of 0.20 and a 95% confidence level, we estimated a sample size of 81 patients.

Results
=======

One hundred nineteen patients met the inclusion criteria. Seventeen patients refused to participate and 16 were unable to comply with study procedures (all were ICU patients), then 86 patients were included in the analysis. The characteristics of participants are summarized in [Table 1](#T1){ref-type="table"}. The mean age of all patients was 44.6±15.4 years, 69.8% were male, and 53.5% were white. Thirty-two patients (37.2%) were HIV positive.

Twenty-seven patients (31.4%) met study criteria for depression (HADS depression score ≥11) and 33 (38.4%) had anxiety (HADS anxiety score ≥11). Scores on all domains of SF-36 were significantly lower than the Brazilian norm scores (p\<0.001) ([Table 2](#T2){ref-type="table"}). Patients with probable depression were more frequently current smokers (44.4%) than patients with no probable depression (15.3%) (p=0.008) ([Table 3](#T3){ref-type="table"}). Low self-esteem was more common in patients with probable depression (55.6% vs. 8.5%, p\<0.001). Probable depression was significantly associated with six of the SF-36 domain scores (physical functioning, general health, vitality, social functioning, role emotional, and mental health). In addition, HIV patients with probable depression had a lower quality of life in all but one domain (physical) of WHOQOL-HIV as compared with HIV patients with no probable depression.

Patients with probable anxiety had more frequently a history of default from TB treatment (69.2%) than patients with no probable anxiety (30.8%) (p=0.016) ([Table 4](#T4){ref-type="table"}). HIV diagnosis was significantly more common in patients with probable anxiety (57.6% vs. 24.5%, p=0.004). Six of the SF-36 domain scores (bodily pain, general health, vitality, social functioning, role emotional, and mental health) were significantly reduced in patients with probable anxiety as compared with patients with no probable anxiety. Significantly lower median social, environmental, and level of independence domains were reported by patients with probable anxiety.

Discussion
==========

The present study was an attempt to evaluate the HRQL and the prevalence of symptoms of depression and anxiety in hospitalized patients with TB. We found that the scores on all domains of SF-36 were significantly lower than the Brazilian norm scores. In addition, more than one third of patients had a diagnosis of depression (31.4%) or anxiety (38.4%), according to HADS.

According to the World Health Organization (WHO), health is defined as a state of complete physical, mental, and social well-being and not a mere absence of disease[@B24]. Therefore, we have to consider that any disease will impact not only on physical health but also on all other aspects of an individual\'s health. Thus, TB has a substantial and encompassing impact on patients\' quality of life. Median domain scores of SF-36 reported by participants in this study were significantly lower than the Brazilian norm scores. Several studies have showed that TB patients reported deficits in their physical and mental well-being in comparison with the general population[@B2][@B3]. Also, one study[@B3] demonstrated that even after treatment completion and microbiological cure, TB patients may still have significantly lower HRQL when compared to U.S. norms.

HRQL was even lower among patients who met depression or anxiety criteria in our study. This is an important finding once we also demonstrated that more than one third of patients met the study criteria for depression or anxiety. Studies have shown that the prevalence of depression and other psychiatric disorders, like generalized anxiety disorder, adjustment disorder and organic brain disorders, is high among patients with TB[@B12][@B25]. Although rates of major depression are expected to be higher in those individuals with medical illness than in the general population, they may be still higher in TB patients[@B26]. In a previous investigation[@B11], depression was present in about 80% of the TB patients, using Beck\'s Depression Inventory. In this study, it was more common in males, and young and elderly patients. In addition, they found that the main factors associated with depression were altered social relationships, among male TB patients, and TB stigma among females. One study also conducted with hospitalized TB patients, the authors demonstrated that 68% of patients met the criteria for depression[@B27]. These different prevalence rates might possibly be due to the differences in the sensitivity of the depression screening instruments used.

Depressive disorder in TB patients has been recognized as a cause of poor treatment compliance and poor disease outcomes, like treatment default or death[@B28]. A retrospective cohort analysis of 440 TB patients has revealed a high rate of relapse due to poor medication compliance, and psychiatric disorders have been implicated[@B29]. Several factors were significantly associated with depression in persons with a TB diagnosis, like personal, socio-demographic (age and financial status), environmental, and clinical (persistent cough)[@B28]. In our study, low self-esteem and current smoking were significantly associated depression.

We found that patients with probable depression were significantly more likely to have low self-esteem. Also, approximately 20% of our sample had criteria for low self-esteem according to Rosenberg scale. Another study with hospitalized patients with TB showed that self-esteem scores dropped in accordance with category of depression, revealing that low self-esteem is a characteristic of depression[@B25]. Stigmatization, negative emotions, social rejection, and isolation were reported by TB patients and could contribute to low self-esteem and impairment of psychosocial well-being[@B2][@B3].

In our study, individuals with TB who screened positive for depression were more likely to be current smokers. The high prevalence of cigarette smoking among people with chronic mental illness is well known[@B30]. Smoking was associated with a nearly two-fold increased risk of depression relative to both never smokers and former smokers[@B31]. This finding is especially important since previous investigations have emphasized the impact of smoking on many aspects of TB, such as TB infection, TB disease, and mortality[@B32][@B33]. Indeed, mortality from TB is four times greater among smokers than among nonsmokers[@B32].

We also found a significantly association between HIV infection and anxiety. Mental health problems such as anxiety and depression in patients infected with HIV is well documented[@B34]. In a study[@B35] that evaluated 649 adult patients with HIV, TB or both, the frequency of any anxiety disorder was 30.8%, and the rates of generalized anxiety disorder were highest for the HIV group. Previous default from TB treatment was also statistically associated with symptoms of anxiety in our study. It is possible that these patients were afraid of the consequences of having abandoned treatment, and this thought is reflected in a higher prevalence of anxiety.

The study has certain limitations. One of the limitations of the study is that it is cross-sectional in design thus casual relationships cannot be inferred. In addition, we evaluated only TB patients and did not compare HRQL scores with a control group. We used the SF-36, and then we compared results to the Brazilian population norms, which could neutralize this limitation. However, the Brazilian norm scores (SF-36) were obtained from a dataset of general population, which can be biased because hospitalization itself and not TB can make patients\' HRQL scores lower, and depression and anxiety scores higher. Comparisons between hospitalized TB patients and patients hospitalized with other diseases, and comparisons between hospitalized TB patients and TB patients treated only in outpatient clinics are needed to get reliable conclusions. In spite of these restrictions, knowing patients\' HRQL is important to understand the well being of TB patients and to plan actions to improve their health outcomes. Also, the identification and prompt treatment of depression and anxiety in patients with TB may be helpful increasing treatment compliance and reducing relapse.

In conclusion, the present study shows that TB patients may have a poor HRQL. Additionally, we found a possible high prevalence of depression and anxiety in this population. Health care workers should be aware of these psychological disorders to enable a better management of these patients. The treatment of these comorbidities may be associated with better TB outcomes.
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[Supplementary Table S1](#S1){ref-type="supplementary-material"}. Descriptive measures of the standardized scores for the eight domains of the 36-item Short Form and for the two summary measures (physical and mental component) of the Brazilian male population by age groups.

[Supplementary Table S2](#S2){ref-type="supplementary-material"}. Descriptive measures of the standardized scores for the eight domains of the 36-item Short Form and for the two summary measures (physical and mental component) of the Brazilian female population by age groups.

###### Supplementary Table S1

Descriptive measures of the standardized scores for the eight domains of the 36-item Short Form and for the two summary measures (physical and mental component) of the Brazilian male population by age groups

###### Supplementary Table S2

Descriptive measures of the standardized scores for the eight domains of the 36-item Short Form and for the two summary measures (physical and mental component) of the Brazilian female population by age groups

###### Characteristics of study patients (n=86)

![](trd-80-69-i001)

  Characteristic                            Value
  ----------------------------------------- -------------------
  Demographic characteristic                
   Age, yr                                  44.6±15.4
   Male sex                                 60 (69.8)
   White race                               46 (53.5)
   \<8 years of schooling^\*^               57 (66.3)
  Current smokers                           21 (24.4)
  Alcoholism                                30 (34.9)
  Drug use                                  29 (33.7)
  Symptoms                                  
   Cough                                    72 (83.7)
   Night sweats                             56 (65.1)
   Fever                                    59 (68.6)
   Weight loss                              72 (83.7)
  Previous TB                               17 (19.8)
  Previous default from TB treatment        13 (15.1)
  Comorbidities                             
   HIV positive                             32 (37.2)
   Diabetes mellitus                        3 (3.5)
  Radiographic patterns                     
   Typical of TB                            56 (65.1)
   Compatible with TB                       30 (34.9)
  HADS depression score ≥11                 27 (31.4)
  HADS anxiety score ≥11                    33 (38.4)
  Rosenberg's Self-Esteem Scale score ≤15   20 (23.3)
  SF-36v2 health domain scores              
   Physical functioning                     45.0 (13.8--86.3)
   Role-physical                            0 (0--25.0)
   Bodily pain                              52.0 (20.0--84.0)
   General health                           45.0 (30.0--60.0)
   Vitality                                 50.0 (32.5--75.0)
   Social functioning                       50.0 (12.5--100)
   Role-emotion                             0 (0--66.6)
   Mental health                            56.0 (28.0--80.0)
   Physical component score                 38.9 (33.6--44.2)
   Mental component score                   40.7 (37.7--44.9)
  WHOQOL-HIV domain scores^†^               
   Physical                                 11.4±2.8
   Psychological                            11.9±2.6
   Social                                   13.0±3.8
   Environmental                            12.2±2.6
   Level of independence                    13.3±2.6
   Spiritual                                10.9±3.8

Values are presented as n (%), mean±standard deviation, or median (interquartile range).

^\*^In Brazil, the primary (or elementary) school cycle is 8 years long.

^†^The scores range between 4 and 20, where higher scores denote higher quality of life.

TB: tuberculosis; HIV: human immunodeficiency virus; HADS: Hospital Anxiety and Depression Scale; SF-36v2: Medical Outcomes Study Short Form-36 version 2; WHOQOL-HIV: World Health Organization Quality of Life instrument for HIV clients.

###### Comparison between SF-36 scores and Brazilian norm scores

![](trd-80-69-i002)

  Scores                     Study group score   Brazilian norm score   p-value
  -------------------------- ------------------- ---------------------- ---------
  Physical functioning       48.4±36.5           80.5±10.4              \<0.001
  Role-physical              15.99±29.7          81.4±7.9               \<0.001
  Bodily pain                52.0±35.3           80.5±6.8               \<0.001
  General health             46.2±19.7           73.2±7.0               \<0.001
  Vitality                   51.6±27.8           74.6±4.6               \<0.001
  Social functioning         52.3±38.8           86.7±5.1               \<0.001
  Role-emotion               29.8±42.5           84.7±5.7               \<0.001
  Mental health              53.7±31.3           76.6±3.7               \<0.001
  Physical component score   38.9±7.9            51.1±3.9               \<0.001
  Mental component score     40.7±4.5            52.3±2.6               \<0.001

Values are presented as mean±standard deviation.

SF-36: Medical Outcomes Study Short Form-36.

###### Factors associated with a HADS depression score ≥11 (probable depression)
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  Variable                             HADS depression score ≥11 (n=27)   HADS depression score \<11 (n=59)   p-value
  ------------------------------------ ---------------------------------- ----------------------------------- ---------
  Age, yr                              43.6±13.4                          45.1±16.3                           0.686
  Male sex                             17 (63.0)                          43 (72.9)                           0.499
  White race                           13 (48.1)                          33 (55.9)                           0.661
  \< 8 years of schooling              19 (70.4)                          38 (64.4)                           0.766
  Current smokers                      12 (44.4)                          9 (15.3)                            0.008
  Cough                                24 (88.9)                          48 (81.4)                           0.534
  Weight loss                          22 (81.5)                          50 (84.7)                           0.947
  Previous TB                          4 (14.8)                           13 (22.0)                           0.625
  Previous default from TB treatment                                      9 (69.2)                            0.617
  HIV                                  14 (51.9)                          18 (30.5)                           0.097
  Smear positive                       17 (63.0)                          41 (69.5)                           0.549
  Cavity                               10 (37.0)                          17 (28.8)                           0.446
  Low self-esteem                      15 (55.6)                          5 (8.5)                             \<0.001
  Probable anxiety                     19 (57.6)                          14 (42.4)                           \<0.001
  SF-36v2 domain                                                                                              
   Physical functioning                25.0 (5.0--45.0)                   65.0 (20.0--95.0)                   0.002
   Role-physical                       0 (0--0)                           0 (0--25.0)                         0.091
   Bodily pain                         41.0 (10.0--64.0)                  52.0 (20.0--100)                    0.157
   General health                      35.0 (25.0--40.0)                  50.0 (40.0--67.0)                   \<0.001
   Vitality                            25.0 (5.0--45.0)                   65.0 (50.0--80.0)                   \<0.001
   Social functioning                  25.0 (12.5--62.5)                  62.5 (25.0--100)                    0.028
   Role-emotion                        0 (0--0)                           0 (0--100)                          0.049
   Mental health                       24.0 (4.0--40.0)                   76.0 (44.0--88.0)                   \<0.001
   Physical component score            38.9 (32.2--44.2)                  38.9 (33.6--44.2)                   0.837
   Mental component score              40.8 (35.6--44.9)                  41.3 (37.7--44.9)                   0.670
  WHOQOL-HIV domain^\*^                                                                                       
   Physical                            10.9±2.8                           11.8±2.8                            0.402
   Psychological                       10.7±2.3                           12.7±2.6                            0.033
   Social                              10.4±3.4                           15.1±2.7                            \<0.001
   Environmental                       10.7±2.1                           13.3±2.4                            0.003
   Level of independence               12.1±2.3                           14.2±2.5                            0.023
   Spiritual                           9.4±3.9                            12.1±3.3                            0.038

Values are presented as mean±standard deviation, number (%), or median (percentile 25--percentile 75).

^\*^n=32.

HADS: Hospital Anxiety and Depression Scale; TB: tuberculosis; HIV: human immunodeficiency virus; SF-36v2: Medical Outcomes Study Short Form-36 version 2; WHOQOL-HIV: World Health Organization Quality of Life instrument for HIV clients.

###### Factors associated with a HADS anxiety score ≥11 (probable anxiety)
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  Variable                             HADS anxiety score ≥11 (n=33)   HADS anxiety score \<11 (n=53)   p-value
  ------------------------------------ ------------------------------- -------------------------------- ---------
  Age, yr                              42.1±10.4                       46.2±17.7                        0.184
  Male sex                             20 (60.6)                       40 (75.5)                        0.223
  White race                           13 (39.4)                       33 (62.3)                        0.065
  \<8 years of schooling               24 (72.7)                       33 (62.3)                        0.445
  Current smokers                      11 (33.3)                       10 (18.9)                        0.208
  Cough                                31 (93.9)                       41 (77.4)                        0.085
  Weight loss                          27 (81.8)                       45 (84.9)                        0.706
  Previous TB                          10 (30.3)                       7 (13.2)                         0.097
  Previous default from TB treatment   9 (69.2)                        4 (30.8)                         0.016
  HIV                                  19 (57.6)                       13 (24.5)                        0.004
  Smear positive                       18 (54.5)                       40 (75.5)                        0.050
  Cavity                               12 (36.4)                       15 (28.3)                        0.433
  Probable depression                  19 (57.6)                       8 (15.1)                         \<0.001
  Low self-esteem                      15 (45.5)                       5 (9.4)                          \<0.001
  SF-36v2 domain                                                                                        
   Physical functioning                35.0 (20.0--85.0)               50.0 (7.5--90.0)                 0.765
   Role-physical                       0 (0--12.5)                     0 (0--37.5)                      0.324
   Bodily pain                         31.0 (10.0--63.0)               62.0 (31.0--100)                 0.004
   General health                      40.0 (25.0--54.5)               47.0 (36.0--63.5)                0.049
   Vitality                            40.0 (15.0--52.5)               65.0 (45.0--80.0)                \<0.001
   Social functioning                  25.0 (12.5--62.5)               75.0 (25.0--100)                 0.001
   Role-emotion                        0 (0--0)                        0 (0--100)                       0.001
   Mental health                       28.0 (12.0--40.0)               76.0 (56.0--88.0)                \<0.001
   Physical component score            38.9 (35.9--44.2)               38.9 (33.6--44.3)                0.971
   Mental component score              40.8 (37.7--44.9)               41.3 (37.7--44.9)                0.724
  WHOQOL-HIV domain (n=32)                                                                              
   Physical                            11.1±3.1                        11.9±2.4                         0.470
   Psychological                       11.3±2.7                        12.7±2.3                         0.144
   Social                              11.9±3.9                        14.7±3.1                         \<0.001
   Environmental                       10.9±2.2                        14.1±1.9                         \<0.001
   Level of independence               12.0±2.3                        15.1±2.0                         \<0.001
   Spiritual                           10.6±4.0                        11.4±3.5                         0.561

Values are presented as mean±standard deviation, number (%), or median (interquartile range).

HADS: Hospital Anxiety and Depression Scale; TB: tuberculosis; HIV: human immunodeficiency virus; SF-36v2: Medical Outcomes Study Short Form-36 version 2; WHOQOL-HIV: World Health Organization Quality of Life instrument for HIV clients.
